'Pharma imports from China reaches $1.74 bn in Apr-Dec 2015'

Image
Press Trust of India New Delhi
Last Updated : May 02 2016 | 4:22 PM IST
India's imports of pharmaceutical products from China has reached USD 1.74 billion during April-December 2015, Parliament was informed today.
In 2014-15, it stood at USD 2.22 billion as against USD 2.11 billion in 2013-14.
India imports drugs and pharmaceutical products from China in the form of raw materials as well as finished products for both domestic consumption and exports.
As per the reports available, in case of 12 essential drugs including Paracetamol and Amoxicillin "there is a significant dependence on imports of drug ingredients and substantial imports of these products are from China".
"One of the reasons for imports from China is the price competitiveness of these products," Commerce and Industry Minister Nirmala Sitharaman said in a written reply to the Lok Sabha.
An inter-ministerial committee has suggested that the API industry (Active Pharmaceutical Ingredient industry) has to be made more viable and there is a need for building up an ecosystem to promote investment in the sector based on global practices.
There are also recommendations for improving the regulatory regime in the country, the minister said.
In a separate reply she said, India's pharmaceutical exports stood at USD 5 billion during April-February 2016 to the US followed by USD 555 million to South Africa and USD 512 million to the UK.
The total exports during April-February 2016 stood at USD 15.36 billion.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 02 2016 | 4:22 PM IST

Next Story